Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Trish Millard"'
Autor:
Trish Millard, Christiana Brenin, Clare Humphrey, Ajay Dhakal, Carla Falkson, Gina Petroni, Nolan A. Wages, Patrick Dillon
Publikováno v:
International Journal of Breast Cancer, Vol 2024 (2024)
Background. Breast cancer has an unacceptably high recurrence rate when any residual disease is found following neoadjuvant treatment of high-risk disease. Based on clinical data suggesting an adjuvant role for epigenetic modifying agents in breast c
Externí odkaz:
https://doaj.org/article/e556c909175542cbad156cca57b31b4d
Autor:
Puja Arora, Laura Talamo, Patrick Dillon, Ryan D. Gentzler, Trish Millard, Michael Salerno, Craig L. Slingluff, Elizabeth M. Gaughan
Publikováno v:
Cardio-Oncology, Vol 6, Iss 1, Pp 1-11 (2020)
Abstract Background Immune checkpoint inhibition is part of standard systemic management for many advanced malignancies. Toxicities from this treatment approach are unpredictable, though usually reversible with management per established guidelines.
Externí odkaz:
https://doaj.org/article/d2c780cf67664090a1984d81ad26ed4f
Autor:
Joseph Mort, Shipra Maheshwari, Nayanika Basu, Patrick Dillon, Kevin Brady, Harry Bear, Trish Millard
Publikováno v:
Case Reports in Oncological Medicine, Vol 2022 (2022)
Checkpoint inhibitors (CPIs) and pegfilgrastim, a long-acting growth factor agent, are vital components of current cancer treatments. Immune-related adverse events (irAEs) such as colitis and pneumonitis are well-established toxicities associated wit
Externí odkaz:
https://doaj.org/article/57f23609f85e486e98c75d343dd73aa1
Publikováno v:
Case Reports in Oncological Medicine, Vol 2019 (2019)
Metastatic carcinomatosis to the liver is a pattern of malignant infiltration that tends to provoke hepatic fibrosis. It is a rare complication of multiple solid tumor types and often seen in the absence of discrete tumor mass in the liver. We report
Externí odkaz:
https://doaj.org/article/4f9055010a8f41bd94c63646dd9b5ac4
Publikováno v:
Cancer Research. 83:PD16-05
Introduction Per NCCN guidelines, patients with stage I-III breast cancer should only have staging work up with CT chest, abdomen, and pelvis and bone scan if there are concerning symptoms, lab abnormalities, or physical exam findings. These patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::609a30e5d3690af9593a3d1c294d9c32
https://doi.org/10.1158/1538-7445.sabcs22-pd16-05
https://doi.org/10.1158/1538-7445.sabcs22-pd16-05
Autor:
Kelly M Shaffer, Erin Kennedy, Jillian Glazer, Anita Clayton, Wendy Cohn, Jennifer Barsky Reese, Trish Millard, Lee Michael Ritterband, Shayna Showalter
Objective: To assess breast cancer survivor, partner, and provider perspectives on the importance of including partners in discussions between providers and survivors about cancer-related sexual concerns. Methods: Partnered female breast cancer survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff7f21fe7db26606a0fce60fd95de375
https://doi.org/10.31219/osf.io/q4enf
https://doi.org/10.31219/osf.io/q4enf
Autor:
Millard T; Trish Millard, Paul R Kunk, Erika Ramsdale, Division of Hematology-Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22908, United States., Kunk PR; Trish Millard, Paul R Kunk, Erika Ramsdale, Division of Hematology-Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22908, United States., Ramsdale E; Trish Millard, Paul R Kunk, Erika Ramsdale, Division of Hematology-Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22908, United States., Rahma OE; Trish Millard, Paul R Kunk, Erika Ramsdale, Division of Hematology-Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22908, United States.
Publikováno v:
World journal of gastrointestinal oncology [World J Gastrointest Oncol] 2016 Oct 15; Vol. 8 (10), pp. 715-724.